SCHEDULE: Driehaus Capital Exits Korro Bio Stake

Driehaus Capital Management LLC has filed an exit notice, reporting zero beneficial ownership in Korro Bio, Inc. common stock.

Summary

• Driehaus Capital Management LLC, an investment adviser, filed an Amendment No. 2 to Schedule 13G regarding its holdings in Korro Bio, Inc.
• This filing serves as an "Exit Filing," indicating that Driehaus Capital Management LLC no longer holds a reportable beneficial ownership interest in Korro Bio, Inc.
• As of the event date of December 31, 2025, Driehaus Capital Management LLC beneficially owns 0 shares of Korro Bio, Inc. common stock.
• This represents 0% of the class of securities, confirming the complete divestment of their previously reportable stake.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is an administrative disclosure of an institutional investor's exit from a position, rather than a direct indicator of Korro Bio, Inc.'s operational or financial performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by institutional investors holding less than 20% of a company's stock, or those who are passive investors. An "Exit Filing" indicates that the reporting entity's beneficial ownership has fallen below the 5% threshold, or they no longer meet the criteria for filing a 13G. This specific filing reflects a change in Driehaus Capital Management LLC's portfolio allocation rather than a direct statement on Korro Bio's industry position.

Key Dates

Keywords

Korro Bio, Driehaus Capital Management, Schedule 13G, Exit Filing, Beneficial Ownership, Common Stock, Investment Adviser